TrAVeRse: acalabrutinib + venetoclax and rituximab for treatment-naïve MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:12 6 months ago 141 Скачать Далее
Acalabrutinib and rituximab as first-line therapy for older patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 448 Скачать Далее
Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 214 Скачать Далее
Acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 249 Скачать Далее
Safety and Efficacy Findings for Acalabrutinib Plus Bendamustine and Rituximab in MCL OncLive 1:51 5 years ago 203 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
Addition of venetoclax to lenalidomide and rituximab in patients with untreated MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 133 Скачать Далее
Rationale for Combining Acalabrutinib With Bendamustine and Rituximab in MCL Targeted Oncology 1:14 5 years ago 208 Скачать Далее
Dr. Phillips on the Safety of Acalabrutinib Plus Bendamustine/Rituximab in MCL OncLive 1:06 5 years ago 103 Скачать Далее
Combined acalabrutinib treatments for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:22 3 years ago 187 Скачать Далее
Does upfront treatment with venetoclax, lenalidomide, and rituximab enhance tumor responses in MCL? Lymphoma Hub 2:35 3 years ago 109 Скачать Далее
Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL OncLive 1:33 6 years ago 395 Скачать Далее
OAsIs trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:30 4 years ago 195 Скачать Далее
Targeted therapy for the treatment of follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:25 2 years ago 496 Скачать Далее
Acalabrutinib monotherapy in R/R MCL: extended follow-up results VJHemOnc – Video Journal of Hematology & HemOnc 3:42 3 years ago 168 Скачать Далее
Phase 2 Study of Acalabrutinib-Lenalidomide-Rituximab in Untreated Mantle Cell Lymphoma Patients WCMNYP JCTO 2:17 4 years ago 136 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
Follow-Up Shows Venetoclax Plus Rituximab has Long-Term Efficacy in CLL Targeted Oncology 1:36 4 years ago 230 Скачать Далее
